HAVRÁNKOVÁ, Eva, Jozef CSÖLLEI, Daniela VULLO, Vladimír GARAJ, Pavel PAZDERA a Claudiu T. SUPURAN. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action. Bioorganic Chemistry. 2018, roč. 77, č. 1, s. 25-37. ISSN 0045-2068. Dostupné z: https://dx.doi.org/10.1016/j.bioorg.2017.12.034.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action
Autoři HAVRÁNKOVÁ, Eva (203 Česká republika, domácí), Jozef CSÖLLEI (203 Česká republika), Daniela VULLO (380 Itálie), Vladimír GARAJ (703 Slovensko), Pavel PAZDERA (203 Česká republika, garant, domácí) a Claudiu T. SUPURAN (380 Itálie).
Vydání Bioorganic Chemistry, 2018, 0045-2068.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10401 Organic chemistry
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.926
Kód RIV RIV/00216224:14310/18:00102164
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.1016/j.bioorg.2017.12.034
UT WoS 000428013300004
Klíčová slova anglicky Sym-Triazine Benzene sulfonamides; Carbonic anhydrase; Enzyme inhibition; Isoform selectivity;
Změnil Změnila: Mgr. Hana Hurtová, učo 244985. Změněno: 23. 2. 2021 12:19.
Anotace
A new series of s-triazine derivatives incorporating sulfanilamide, homosulfanilamide, 4-aminoethylbenzenesulfonamide and piperazine or aminoalcohol structural motifs is reported. Molecular docking was exploited to select compounds from virtual combinatorial library for synthesis and subsequent biological evaluation. The compounds were prepared by using step by step nucleophilic substitution of chlorine atoms from cyanuric chloride (2,4,6-trichloro-1,3,5-triazine). The compounds were tested as inhibitors of physiologically relevant carbonic anhydrase (CA, EC 4.2.1.1) isoforms. Specifically, against the cytosolic hCA I, II and tumor-associated hCA IX. These compounds show appreciable inhibition. hCA I was inhibited with KIs in the range of 8.5–2679.1 nM, hCA II with KIs in the range of 4.8–380.5 nM and hCA IX with KIs in the range of 0.4–307.7 nM. As other similar derivatives, some of the compounds showed good or excellent selectivity ratios for inhibiting hCA IX over hCA II, of 3.5–18.5. 4-[({4-Chloro-6-[(4-hydroxyphenyl)amino]-1,3,5-triazin-2-yl}amino)methyl] benzene sulfonamide demonstrated subnanomolar affinity for hCA IX (0.4 nM) and selectivity (18.50) over the cytosolic isoforms. This series of compounds may be of interest for the development of new, unconventional anticancer drugs targeting hypoxia-induced CA isoforms such as CA IX.
VytisknoutZobrazeno: 18. 9. 2024 21:49